These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2733248)

  • 1. Correlation between the depth of inverted T waves and the serum level of ferritin in a deferoxamine-treated patient with primary hemochromatosis and hyperthyroidism.
    Kurabayashi H; Kubota K; Tamura J; Yanagisawa T; Shirakura T
    Jpn J Med; 1989; 28(2):243-6. PubMed ID: 2733248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in the thyroid function by use of deferoxamine in a patient with hemochromatosis complicated by hyperthyroidism.
    Kubota K; Kurabayashi H; Tamura J; Kawada E; Tamura K; Nagashima K; Shirakura T
    J Med; 1992; 23(1):75-7. PubMed ID: 1573342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of increased serum ferritin levels in patients with hyperthyroidism.
    Kubota K; Tamura J; Kurabayashi H; Shirakura T; Kobayashi I
    Clin Investig; 1993 Dec; 72(1):26-9. PubMed ID: 8136612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iron chelate treatment of hereditary sideroblastic anemia complicated by hemochromatosis].
    Kremp L; Girot R; Alliot S; Najean Y; Douchain F; Hongre JF
    Arch Fr Pediatr; 1983; 40(6):475-7. PubMed ID: 6625846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myocardiopathy caused by iron deposition. Treatment with chelating agents].
    Rodríguez Reguero JJ; Iglesias Cubero G; Espolita Santos A; López de la Iglesia JM; Enríquez Martín J; Tomás Mauri J; López-Negrete L
    Rev Esp Cardiol; 1985; 38(5):356-7. PubMed ID: 4081244
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparing Care of the Primary and Secondary Hemochromatosis Patients.
    Becker S
    J Infus Nurs; 2020; 43(2):65-69. PubMed ID: 32106193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration.
    Walters GO; Jacobs A; Worwood M; Trevett D; Thomson W
    Gut; 1975 Mar; 16(3):188-92. PubMed ID: 804432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents.
    Abuid J; Larsen PR
    J Clin Invest; 1974 Jul; 54(1):201-8. PubMed ID: 4134836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramuscular deferoxamine in hereditary hemochromatosis.
    Polo-Romero FJ
    Am J Hematol; 2006 Mar; 81(3):225-6. PubMed ID: 16493613
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of subcutaneous deferoxamine in a child with hemochromatosis associated with congenital dyserythropoietic anemia, type I.
    Smithson WA; Perrault J
    Mayo Clin Proc; 1982 May; 57(5):322-5. PubMed ID: 7078263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combined therapy with deferoxamine and deferiprone on serum ferritin level of beta-thalassemic patients.
    Mirbehbahani N; Jahazi A; Rahim Abad HH
    Hematology; 2012 May; 17(3):183-6. PubMed ID: 22664119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-insulin-dependent diabetes mellitus and elevated serum ferritin level.
    Kaye TB; Guay AT; Simonson DC
    J Diabetes Complications; 1993; 7(4):246-9. PubMed ID: 8219368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal serum ferritin concentrations in precirrhotic hemochromatosis.
    Wands JR; Rowe JA; Mezey SE; Waterbury LA; Wright JR; Halliday JW; Isselbacher KJ; Powell LW
    N Engl J Med; 1976 Feb; 294(6):302-5. PubMed ID: 1246269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Treatment of Iron-Overload Cardiomyopathy in Hereditary Hemochromatosis With Deferoxamine and Deferiprone.
    Tauchenová L; Křížová B; Kubánek M; Fraňková S; Melenovský V; Tintěra J; Kautznerová D; Malušková J; Jirsa M; Kautzner J
    Can J Cardiol; 2016 Dec; 32(12):1574.e1-1574.e3. PubMed ID: 27789107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of post-transfusion iron overload by deferoxamine].
    de Montalembert M; Llados A; Hannedouche T; Girot R
    Arch Fr Pediatr; 1989 Feb; 46(2):99-105. PubMed ID: 2735804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary hemochromatosis].
    Dantas W
    Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic hemochromatosis: serum ferritin concentrations during therapy by phlebotomy.
    Garry PJ; Saiki JH
    Clin Chem; 1982 Aug; 28(8):1806-8. PubMed ID: 7094303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SERUM FERRITIN CONCENTRATION IS NOT A RELIABLE BIOMARKER OF IRON OVERLOAD DISORDER PROGRESSION OR HEMOCHROMATOSIS IN THE SUMATRAN RHINOCEROS (DICERORHINUS SUMATRENSIS).
    Roth TL; Reinhart PR; Kroll JL
    J Zoo Wildl Med; 2017 Sep; 48(3):645-658. PubMed ID: 28920821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte membrane ferritin in hemochromatosis.
    Adams PC; Flanagan PR; Chau L; White M; Lazarovits A
    Clin Invest Med; 1991 Oct; 14(5):402-8. PubMed ID: 1742918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.